Annual Report

Overview

The report presents JW Therapeutics' first ESG report for 2020, covering its core business, factories, offices and laboratories in Shanghai and Suzhou. The company places the Board at the highest level of ESG oversight and uses stakeholder engagement and a materiality assessment to identify priority topics. Environmental KPIs include 5,448.77 tCO2e of total GHG emissions and 8,892.37 MWh of total energy consumption. The report also discloses a 364-person workforce and initiatives covering employee inclusion, training, health and safety, integrity, supply-chain management and community engagement.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services